Navigating Your Acute Heart Failure Patient in Emergency and Pre-Discharge Phase
Budi Yuli Setianto(1*)
(1) Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada – Dr. Sardjito General Hospital, Yogyakarta, Indonesia
(*) Corresponding Author
Abstract
Heart failure (HF) leads to frequent hospitalizations. The presence of re-hospitalization risk among patientshospitalized for heart failure is important, especially hemodynamic instability and neurohormonal over activation. ARNI is needed to restore the balance of neurohormonal system in HF. PARADIGM-HF study provide insight on long term benefit of ARNI (i.e. sacubitril/valsartan) in ambulatory setting. How is the evidence of ARNI use for in hospitalization phase of HF? PIONEER and TRANSITION showed that initiation of sacubitril/valsartan shortly after an ADHF event is feasible and well tolerated. In-hospital initiation of sacubitril/valsartan is associated with early and sustained improvements in biomarkers of cardiac wall stress and myocardial injury, indicating pathophysiological benefits in a wide range of HFrEF patients.
Full Text:
PDFDOI: https://doi.org/10.22146/aci.47680
Article Metrics
Abstract views : 1216 | views : 1736Refbacks
- There are currently no refbacks.
Copyright (c) 2019 Budi Yuli Setianto
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
ACI (Acta Cardiologia Indonesiana) is indexed by:
ACI (Acta Cardiologia Indonesiana) is published by:
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
Address: Radiopoetro Building 2nd Floor, West Wing, Farmako Street, Sekip, Yogyakarta, Indonesia 55281
ACI (Acta Cardiologia Indonesiana) is endorsed by: